Saccharomyces cerevisiae

(redirected from Cerevisiae)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for Saccharomyces cerevisiae

used as a leaven in baking and brewing

References in periodicals archive ?
cerevisiae was provided by Grubiodeq Lab (Biotechnology Group, University of Cordoba), to which testing was carried out to evaluate probiotic capacity thereof.
cerevisiae under oxygen-limited fermentative conditions.
Se utilizo la cepa Saccharomyces cerevisiae var boulardii procedente del cepario de la Unidad de Investigacion en Microbiologia Ambiental (UIMA)--Seccion Micologia.
Bioethanol can be produced by many kinds of microorganisms, of which Saccharomyces cerevisiae is the most employed species for industrial production (Widiastuti et al.
Saccharomyces cerevisiae is the main species of yeast employed for ethanol production at industrial level since this microorganism is easy to handle, shows no high nutritional needs, can easily withstand 10-15 % ethanol (10).
They then investigated engineering the yeast Saccharomyces cerevisiae to express a gene that allowed it to convert the nitrile-containing chemical cyanamide into urea, from which it could obtain nitrogen.
Feed conversion ratio: The FCR showed improvement in broilers fed diets containing yeast, Toyocerine(r) and mixture of both (Saccharomyces cerevisiae + Toyocerine(r)) compared to birds fed diets without probiotic supplementation (Table 2).
This updated edition of the Cold Spring Harbor Laboratory course manual provides eleven teaching experiments and protocols, and recipes for the standard techniques and reagents used in the study of yeast Saccharomyces cerevisiae as a model of multiple cellular processes.
For instance, supplementing beef cattle with Saccharomyces cerevisiae could raise the live weight by 7.
In fact, assays using the eukaryotic yeast Saccharomyces cerevisiae have been employed to evaluate the antioxidant activity of flavonoids and vegetable extracts (Soares et al.
Based on the findings of a first clinical trial, which were recently published in the journal Digestive and Liver Disease, Health Canada has granted Lesaffre Human Care a new condition-specific claim for ibSium, the company's unique strain of Saccharomyces cerevisiae CNCM 1-3856.
cerevisiae Growth and the Ability of Pseudomoanas sp and Bacillus sp to be Phosphorus Solubilizers for Industrial Usage